Taurine 11 pp 415-427 | Cite as

Perinatal Taurine Supplementation Prevents the Adverse Effects of Maternal Dyslipidemia on Growth and Cardiovascular Control in Adult Rat Offspring

  • Atcharaporn Thaeomor
  • Chonticha Tangnoi
  • Suphaket Seanthaweesuk
  • Nuntiya Somparn
  • Sanya RoysommutiEmail author
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1155)


Maternal dyslipidemia induces metabolic and cardiovascular disorders in adult offspring. This study tests the hypothesis that perinatal taurine supplementation prevents the adverse effects of maternal dyslipidemia on growth and cardiovascular function in adult rat offspring. Female Wistar rats were fed normal rat chow and water with (Dyslipidemia) or without dyslipidemia induction (Control) by intraperitoneal Triton WR-1339 injection, three times a week for 4 weeks. The female Control and Dyslipidemia rats were supplemented with (Control+T, Dyslipidemia+T) or without 3% taurine in water from conception to weaning. After weaning, male and female offspring were fed normal rat chow and water throughout the experiment. At 16 weeks of age, body weights significantly increased in male but not female Dyslipidemia compared to other groups, while visceral fat content significantly increased in both male and female Dyslipidemia groups. Further, both sexes displayed similar high fasting blood sugar and normal plasma leptin levels among the groups. While plasma total cholesterol and triglycerides significantly increased only in female Dyslipidemia, low-density lipoprotein cholesterol increased in both male and female Dyslipidemia groups. Mean arterial pressures and heart rates significantly increased, while baroreflex sensitivity decreased in male and female Dyslipidemia compared to all other groups. High-density lipoprotein cholesterol did not significantly different among male or female groups. These changes of the male and female Dyslipidemia group were ameliorated by perinatal taurine supplementation. The present study indicates that perinatal taurine supplementation prevents the adverse effects of maternal dyslipidemia on growth and cardiovascular function in both male and female, adult offspring.


Baroreflex Hypercholesterolemia Hypertension Maternal dyslipidemia Perinatal taurine 



baroreflex sensitivity control of heart rate


Control plus taurine supplementation


Dyslipidemia plus taurine supplementation


high-density lipoprotein cholesterol


low-density lipoprotein cholesterol




sodium nitroprusside



This work was supported by the Thailand Research Fund (TRF) TRG5880049 and the National Research Council Thailand (NRCT) SUT1-104-59-24-13, Thailand.


  1. Borghi C, Urso R, Cicero AF (2017) Renin-angiotensin system at the crossroad of hypertension and hypercholesterolemia. Nutr Metab Cardiovasc Dis 27:115–120CrossRefGoogle Scholar
  2. Christensen JJ et al (2016) LDL cholesterol in early pregnancy and offspring cardiovascular disease risk factors. J Clin Lipidol 10:1369–1378CrossRefGoogle Scholar
  3. Elahi MM, Cagampang FR, Anthony FW, Curzen N, Ohri SK, Hanson MA (2008) Statin treatment in hypercholesterolemic pregnant mice reduces cardiovascular risk factors in their offspring. Hypertension 51:939–944CrossRefGoogle Scholar
  4. Ganda OP, Bhatt DL, Mason RP, Miller M, Boden WE (2018) Unmet need for adjunctive dyslipidemia therapy in hypertriglyceridemia management. J Am Coll Cardiol 72:330–343CrossRefGoogle Scholar
  5. Ghio A, Bertolotto A, Resi V, Volpe L, Di CG (2011) Triglyceride metabolism in pregnancy. Adv Clin Chem 55:133–153CrossRefGoogle Scholar
  6. Guarino D, Nannipieri M, Iervasi G, Taddei S, Bruno RM (2017) The role of the autonomic nervous system in the pathophysiology of obesity. Front Physiol 8:665CrossRefGoogle Scholar
  7. Herrera E, Ortega-Senovilla H (2014) Lipid metabolism during pregnancy and its implications for fetal growth. Curr Pharm Biotechnol 15:24–31CrossRefGoogle Scholar
  8. Herrera E, Ortega-Senovilla H (2018) Implications of lipids in neonatal body weight and fat mass in gestational diabetic mothers and non-diabetic controls. Curr Diab Rep 18:7CrossRefGoogle Scholar
  9. Juritsch A, Tsai YT, Patel MS, Rideout TC (2017) Transcriptional control of enterohepatic lipid regulatory targets in response to early cholesterol and phytosterol exposure in apoE(-/-) mice. BMC Res Notes 10:529CrossRefGoogle Scholar
  10. Mendelson MM, Lyass A, O’Donnell CJ, D’Agostino RB Sr, Levy D (2016) Association of maternal prepregnancy dyslipidemia with adult offspring dyslipidemia in excess of anthropometric, lifestyle, and genetic factors in the Framingham heart study. JAMA Cardiol 1:26–35CrossRefGoogle Scholar
  11. Murakami S (2017) The physiological and pathophysiological roles of taurine in adipose tissue in relation to obesity. Life Sci 186:80–86CrossRefGoogle Scholar
  12. Narverud I et al (2011) Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor alpha system and interleukin-10. Atherosclerosis 214:163–168CrossRefGoogle Scholar
  13. Pan WH, Chiang BN (1995) Plasma lipid profiles and epidemiology of atherosclerotic diseases in Taiwan – a unique experience. Atherosclerosis 118:285–295CrossRefGoogle Scholar
  14. Petrie JR, Guzik TJ, Touyz RM (2018) Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol 34:575–584CrossRefGoogle Scholar
  15. Predazzi IM et al (2015) Sex-specific parental effects on offspring lipid levels. J Am Heart Assoc 4:e001951CrossRefGoogle Scholar
  16. Racasan S, Braam B, van der Giezen DM, Goldschmeding R, Boer P, Koomans HA, Joles JA (2004) Perinatal L-arginine and antioxidant supplements reduce adult blood pressure in spontaneously hypertensive rats. Hypertension 44:83–88CrossRefGoogle Scholar
  17. Roysommuti S, Wyss JM (2014) Perinatal taurine exposure affects adult arterial pressure control. Amino Acids 46:57–72CrossRefGoogle Scholar
  18. Seravalle G, Grassi G (2016) Sympathetic nervous system, hypertension, obesity and metabolic syndrome. High Blood Press Cardiovasc Prev 23:175–179CrossRefGoogle Scholar
  19. Serhiyenko VA, Serhiyenko AA (2018) Cardiac autonomic neuropathy: risk factors, diagnosis and treatment. World J Diabetes 9:1–24CrossRefGoogle Scholar
  20. Silverio R et al (2017) Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer. Lipids Health Dis 16:159CrossRefGoogle Scholar
  21. Szostak-Wegierek D (2014) Intrauterine nutrition: long-term consequences for vascular health. Int J Women’s Health 6:647–656CrossRefGoogle Scholar
  22. Thaeomor A, Teangphuck P, Chaisakul J, Seanthaweesuk S, Somparn N, Roysommuti S (2017) Perinatal taurine supplementation prevents metabolic and cardiovascular effects of maternal diabetes in adult rat offspring. Adv Exp Med Biol 975:295–305CrossRefGoogle Scholar
  23. Wyss JM, Roysommuti S, King K, Kadisha I, Regan CP, Berecek KH (1994) Salt-induced hypertension in normotensive spontaneously hypertensive rats. Hypertension 23:791–796CrossRefGoogle Scholar
  24. Wyss JM, Mozaffari MS, Roysommuti S (1995) Contribution of the sympathetic nervous system to salt-sensitivity in lifetime captopril-treated spontaneously hypertensive rats. J Hypertens 13:1037–1042CrossRefGoogle Scholar
  25. Yamori Y, Taguchi T, Hamada A, Kunimasa K, Mori H, Mori M (2010) Taurine in health and diseases: consistent evidence from experimental and epidemiological studies. J Biomed Sci 17(Suppl 1):S6CrossRefGoogle Scholar
  26. Zarzecki MS, Araujo SM, Bortolotto VC, de Paula MT, Jesse CR, Prigol M (2014) Hypolipidemic action of chrysin on Triton WR-1339-induced hyperlipidemia in female C57BL/6 mice. Toxicol Rep 1:200–208CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Atcharaporn Thaeomor
    • 1
  • Chonticha Tangnoi
    • 1
  • Suphaket Seanthaweesuk
    • 2
  • Nuntiya Somparn
    • 2
  • Sanya Roysommuti
    • 3
    Email author
  1. 1.School of Preclinic, Institute of ScienceSuranaree University of TechnologyNakhon RatchasimaThailand
  2. 2.Department of Preclinical Science, Faculty of MedicineThammasat UniversityPathumthaniThailand
  3. 3.Department of Physiology, Faculty of MedicineKhon Kaen UniversityKhon KaenThailand

Personalised recommendations